PTON vs TBPH · P/E 92, rev $2.49B vs P/E 7.5, rev $18.8M
Peloton Interactive Inc (PTON) versus Theravance Biopharma Inc (TBPH) — a side-by-side from cached financials, not a winner call.
Peloton Interactive Inc (PTON) is a leisure company listed on NASDAQ.
Theravance Biopharma Inc (TBPH) is a biotechnology company listed on NASDAQ.
Latest reported PTON revenue for 2025-06-30 was $2.49B. Net income was -$118.9M. Revenue was down 7.8% from 2024-06-30 to 2025-06-30. PTON currently screens at market cap $2.39B and trailing P/E 92.2.
Latest reported TBPH revenue for 2024-12-31 was $18.8M. Net income was -$15.5M. Revenue was up 11.2% from 2024-09-30 to 2024-12-31. TBPH currently screens at market cap $861.5M and trailing P/E 7.5.
PTON currently screens at market cap $2.39B and trailing P/E 92.2. TBPH currently screens at market cap $861.5M and trailing P/E 7.5.
Not investment advice. Open the PTON and TBPH stock pages for the full models.
Not investment advice.